பரிமாணம் சிகிச்சை இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பரிமாணம் சிகிச்சை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பரிமாணம் சிகிச்சை இன்க் Today - Breaking & Trending Today

Mark Ahn (Release No. LR-25024; Feb. 5, 2021)


Litigation Release No. 25024 / February 5, 2021
Securities and Exchange Commission v. Mark Ahn, No. 1:21-cv-10203 (D. Mass. filed February 5, 2021)
On February 5, 2021, the Securities and Exchange Commission charged Oregon resident Mark Ahn with insider trading in the securities of Massachusetts-based pharmaceutical company Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement.
The SEC s complaint, filed in federal district court in Massachusetts, charges Ahn with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The SEC seeks penalties, injunctive relief, and an order barring Ahn from serving as an officer or director of any SEC-reporting company. ....

United States , Asita Obeyesekere , Mark Ahn , Xinyue Angela Lin , Nita Klunder , Exchange Commission , Bureau Of Investigation , Securities Exchange , Financial Industry Regulatory Authority , Dimension Therapeutics Inc , Federal Bureau Of Investigation , Dimension Therapeutics , Securities Exchange Act , Sofia Hussain , Boston Regional , Federal Bureau , Financial Industry Regulatory , ஒன்றுபட்டது மாநிலங்களில் , குறி அஹ்ன் , பரிமாற்றம் தரகு , பணியகம் ஆஃப் விசாரணை , பத்திரங்கள் பரிமாற்றம் , நிதி தொழில் ஒழுங்குமுறை அதிகாரம் , பரிமாணம் சிகிச்சை இன்க் , கூட்டாட்சியின் பணியகம் ஆஃப் விசாரணை , பரிமாணம் சிகிச்சை ,

Dynacure Announces Appointment of Jean M. Franchi to its Board of Directors


Share this article
Share this article
STRASBOURG, France and PHILADELPHIA, Jan. 21, 2021 /PRNewswire/  Dynacure, a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options, announced today the appointment of Jean M. Franchi to its Board of Directors.  Ms. Franchi is an experienced board member, finance executive and operational leader with more than three decades of experience in the life sciences industry.
I am very pleased to welcome Jean to the Dynacure Board, said Georges Gemayel, Chairman of the Board of Directors of Dynacure. Jean will be a valuable addition to our team, bringing expertise in financial and long-term strategies, and we look forward to her guidance. ....

United States , Georges Gemayel , Stephane Van Rooijen , Jeanm Franchi , Centronuclear Myopathies , Hofstra University , Merrimack Pharmaceuticals , Tekla Capital Management , Dimension Therapeutics Inc , Business Administration , Ionis Pharmaceuticals , Dynacure Board , Chief Financial Officer , Good Start Genetics , Dimension Therapeutics , Senior Vice President , Corporate Finance , Chief Executive Officer , Hereditary Spastic Paraplegias , Andera Partners , Bpifrance Large Venture , Fonds Bioth , Maladies Rares , Kurma Partners , Perceptive Advisors , ஒன்றுபட்டது மாநிலங்களில் ,